Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo,
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
Company presentation scheduled on Tuesday, March 4th at 9:10am ET –– EyePoint to provide enrollment update for ongoing DURAVYU™ Phase 3 pivotal
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
A live audio webcast of the presentation will be available under "Events & Presentations” in the News & Events section of the Company's website at www.primemedicine.com. A replay of the webcast will be available on the Prime Medicine website for 30 days following the presentation.
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 2:30 p.
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be available on the website following the conclusion of the event.
argenx to Present at TD Cowen 45th Annual Healthcare Conference
A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.
MediWound to Present at the 45th Annual TD Cowen Health Care Conference
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Chief Executive Officer Ofer Gonen will present a corporate overview at the upcoming 45th Annual TD Cowen Health Care Conference,
atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage
Morningstar3d
agilon health to Participate in TD Cowen’s 45th Annual Health Care Conference
announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and ...
Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...